Symbiosal(®) and lowering of blood pressure and reduced risk of hypertension: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006

Following an application from Han‐Biotech GmbH, submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Germany, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scien...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:EFSA J
Huvudupphovsmän: Turck, Dominique, Bresson, Jean‐Louis, Burlingame, Barbara, Dean, Tara, Fairweather‐Tait, Susan, Heinonen, Marina, Hirsch‐Ernst, Karen Ildico, Mangelsdorf, Inge, McArdle, Harry J, Naska, Androniki, Neuhäuser‐Berthold, Monika, Nowicka, Grażyna, Pentieva, Kristina, Sanz, Yolanda, Sjödin, Anders, Stern, Martin, Tomé, Daniel, Van Loveren, Henk, Vinceti, Marco, Willatts, Peter, Martin, Ambroise, Strain, Sean (J.J.), Siani, Alfonso
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2018
Ämnen:
Scientific Opinion
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7009733/
https://ncbi.nlm.nih.gov/pubmed/32625995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2903/j.efsa.2018.5364
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk